AbbVie Valuation
| 4AB Stock | EUR 173.96 1.94 1.10% |
At this time, the firm appears to be overvalued. AbbVie Inc shows a prevailing Real Value of €145.61 per share. The current price of the firm is €173.96. Our model approximates the value of AbbVie Inc from analyzing the firm fundamentals such as profit margin of 0.20 %, and Return On Equity of 0.72 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AbbVie's price fluctuation is very steady at this time. Calculation of the real value of AbbVie Inc is based on 3 months time horizon. Increasing AbbVie's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AbbVie stock is determined by what a typical buyer is willing to pay for full or partial control of AbbVie Inc. Since AbbVie is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AbbVie Stock. However, AbbVie's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 173.96 | Real 145.61 | Hype 173.96 |
The real value of AbbVie Stock, also known as its intrinsic value, is the underlying worth of AbbVie Inc Company, which is reflected in its stock price. It is based on AbbVie's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AbbVie's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AbbVie Inc helps investors to forecast how AbbVie stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AbbVie more accurately as focusing exclusively on AbbVie's fundamentals will not take into account other important factors: AbbVie Total Value Analysis
AbbVie Inc is presently estimated to have takeover price of 331.38 B with market capitalization of 256.3 B, debt of 59.13 B, and cash on hands of 5.23 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AbbVie fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
331.38 B | 256.3 B | 59.13 B | 5.23 B |
AbbVie Investor Information
About 72.0% of the company shares are owned by institutions such as pension funds. The company has Price/Earnings To Growth (PEG) ratio of 1.29. AbbVie Inc recorded earning per share (EPS) of 6.25. The entity last dividend was issued on the 13th of April 2023. Based on the measurements of operating efficiency obtained from AbbVie's historical financial statements, AbbVie Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.AbbVie Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AbbVie has an asset utilization ratio of 41.82 percent. This implies that the Company is making €0.42 for each dollar of assets. An increasing asset utilization means that AbbVie Inc is more efficient with each dollar of assets it utilizes for everyday operations.AbbVie Ownership Allocation
AbbVie holds a total of 1.77 Billion outstanding shares. The majority of AbbVie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AbbVie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AbbVie. Please pay attention to any change in the institutional holdings of AbbVie Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.AbbVie Profitability Analysis
The company reported the revenue of 58.05 B. Net Income was 11.84 B with profit before overhead, payroll, taxes, and interest of 41.53 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AbbVie's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AbbVie and how it compares across the competition.
About AbbVie Valuation
The stock valuation mechanism determines AbbVie's current worth on a weekly basis. Our valuation model uses a comparative analysis of AbbVie. We calculate exposure to AbbVie's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AbbVie's related companies.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 30000 people.
8 Steps to conduct AbbVie's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AbbVie's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AbbVie's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AbbVie's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AbbVie's revenue streams: Identify AbbVie's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AbbVie's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AbbVie's growth potential: Evaluate AbbVie's management, business model, and growth potential.
- Determine AbbVie's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AbbVie's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |